Archives

• • OCTOBER 16, 2019
  • 0 COMMENTS

  BRAIN NEUROMODULATION CONFERENCE

  BRAIN NEUROMODULATION CONFERENCE CO-PROGRAM DIRECTORS Thomas Schwartz, MD, Interim Chair, Professor, Department of Psychiatry, and Senior Associate Dean, College of Medicine, SUNY Upstate Medical University Khalid Sethi, MD, FACS, FAANS, Co-Director of Surgical Services & Chief of Surgery UHSH, Director of Neurosurgery, UHS Medical Group, Johnson City, NY RECOMMENDED AUDIENCE Physicians, psychiatrists, psychologists, psychiatric nurseRead more

  • neuro
  • Health,
  • News
• • JUNE 6, 2018
  • 1 COMMENT
  

  Building a World-Class Neurosurgical Institute

  Building a World-Class Neurosurgical Institute Since the mid-1960s, Southern New York Neurosurgical Group has been pushing the boundaries of neurological and neurosurgical care through the services of internationally recognized experts, clinical trials, the introduction of advanced technology and consistently outstanding outcomes. Now, as the practice expands to Syracuse — and adopts the name Empire State

  Read more

  • neuro
  • Uncategorized
• • FEBRUARY 12, 2017
  • 0 COMMENTS
  

  Southern New York Neurosurgical group partners to become ESNI – Empire State Neurosurgical Institute

  Empire State Neurosurgical Institute (ESNI) is an established center of excellence that provides advanced comprehensive neurosurgical treatment strategies. The staff specializes in areas of brain and spine tumors, cerebrovascular diseases and degenerative diseases of the spine. ESNI is committed to maximizing conservative care, where appropriate, prior to making a surgical recommendation. We have gone to

  Read more

  • neuro
  • General,
  • Ophthalmology Clinic
• • FEBRUARY 6, 2017
  • 0 COMMENTS

  Our Founder’s Philosophy

  Read more

  • neuro
  • General,
  • Health,
  • NeuroSciences Group,
  • News,
  • Primary Health Care
• • JANUARY 15, 2017
  • 0 COMMENTS
  

  First Artificial Disc Recommended For FDA Training Awarded To SNY Neurosurgical

  In June, 2004, the FDA Advisory Panel unanimously recommended the approval of the first Artificial Disc for degenerative disc disease. The FDA is expected to approve the Charite™ Artificial Disc available through DePuy, Inc., a Johnson & Johnson company, sometime in September, 2004. DePuy Spine, Inc. presented results from a two-year, 15 center randomized U.S.

  Read more

  • neuro
  • General,
  • Health,
  • Rehabilitation

Photostream